As global biotech investment patterns shift, investors are turning their eyes to Asia-Pacific. While China remains a powerhouse, emerging hubs like Singapore and South Korea are quickly gaining attention for their political stability, strong IP protection, and innovation-friendly policies.
Why are APAC biotech markets suddenly so appealing to investors? And how are these emerging hubs reshaping the future of global biotech innovation?
On Wealth Tracker, Hongbin Jeong speaks to Fabio La Mola, Partner at Bain & Company, to find out more.

The Big Story: Who is Mojtaba Khamenei, Iran’s new Supreme Leader and how might his rule change the US‑Iran war?
13:46

Wealth Tracker: Why gold & silver are the new first investment for Gen Z and Millennials
17:55

What's Trending: Would you live with your parents to splurge on luxury? And is this energy habit causing you to fight at home?
17:40